Bob Josefsberg
Corporate Officer/Principal presso Chamberlain Healthcare Public Relations
Profilo
Bob Josefsberg is currently working as the Executive Vice President at Chamberlain Healthcare Public Relations.
Prior to this, he worked as the Head-Media at Karuna Therapeutics, Inc.
Posizioni attive di Bob Josefsberg
Società | Posizione | Inizio |
---|---|---|
Chamberlain Healthcare Public Relations
Chamberlain Healthcare Public Relations Miscellaneous Commercial ServicesCommercial Services Chamberlain Healthcare Public Relations provides public relations services to the healthcare industry. It offers data strategy and communications; message and content development; advocacy relations; consumer media campaigns; traditional and social media; spokesperson recruitment and management; issues and crisis management and national and grassroots programming. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
Precedenti posizioni note di Bob Josefsberg
Società | Posizione | Fine |
---|---|---|
KARA THER | Public Communications Contact | 18/03/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Chamberlain Healthcare Public Relations
Chamberlain Healthcare Public Relations Miscellaneous Commercial ServicesCommercial Services Chamberlain Healthcare Public Relations provides public relations services to the healthcare industry. It offers data strategy and communications; message and content development; advocacy relations; consumer media campaigns; traditional and social media; spokesperson recruitment and management; issues and crisis management and national and grassroots programming. The company is headquartered in New York, NY. | Commercial Services |
Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Bob Josefsberg